Histogen Inc logo

HSTO - Histogen Inc News Story

$0.71 -0.0  -3.0%

Last Trade - 27/10/21

Sector
Healthcare
Size
Micro Cap
Market Cap £22.2m
Enterprise Value £4.68m
Revenue £1.02m
Position in Universe 6384th / 7275

Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Tue 31st August, 2021 9:05pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210831:nGNX3r61cz&default-theme=true


SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a
clinical-stage therapeutics company focused on developing potential
first-in-class restorative therapeutics that ignite the body’s natural
process to repair and maintain healthy biological function, today announced
that Richard W. Pascoe, President and Chief Executive Officer of Histogen,
will present at the H.C. Wainwright 23(rd) Annual Global Investment
Conference.

Presentation Details

The presentation will be available for on-demand listening beginning Monday,
September 13, 2021 at 7:00 AM Eastern Time and can be accessed using the link
https://journey.ct.events/view/c065249e-2ede-44de-ad16-38ecae89a28d.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing
potential first-in-class restorative therapeutics that ignite the body’s
natural process to repair and maintain healthy biological function.
Histogen’s innovative technology platform utilizes cell conditioned media
and extracellular matrix materials produced by hypoxia-induced multipotent
cells. Histogen’s proprietary, reproducible manufacturing process provides
targeted solutions across a broad range of therapeutic indications, including
joint cartilage regeneration, spinal disk repair, tendon, ligament and other
soft tissue repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO 
Histogen Inc. 
ir@histogen.com


(https://www.globenewswire.com/NewsRoom/AttachmentNg/5a42687c-9cb2-4dbf-960e-60f9776dd598)



GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.